Director, HEOR Strategy Eyecare, International Launch Lead

Company Description

Abb Vie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  Follow @abbvie on X, Facebook, Instagram, You Tube, Linked In and Tik Tok.

The Director, Health Economics & Outcomes Research (HEOR) leads the strategic development & execution of high-quality evidence for an enterprise-critical gene therapy in retinal diseases. He or she directly contributes to the launch evidence required for JCA and HTA, and serves as the brand/asset leader representing HEOR on cross functional asset/brand teams, ensuring HTA/payer evidence requirements are reflected in the overall asset strategy.

He or she may be accountable for more than one asset and/or indication, and oversees evidence alignment across key international markets.

Oversees the design and conduct of projects and effectively communicates the findings and strategic impact of findings to internal and external audiences.

• Provides product leadership to HEOR strategic direction consistent with business goals established in conjunction with the appropriate cross‑functional partners. These activities include but are not limited to: multi‑stakeholder unmet need evidence, cost‑effectiveness and economic modeling, comparative effectiveness analyses, real‑world evidence, patient‑reported outcomes, and working with external experts to substantiate the case for gene therapy policy change.
• Ensures project plan integrates and aligns with the product strategic plans from matrix teams as well as commercial interests. Provides updates on execution of plans to product as well as functional management, owns, then shares project execution decisions. In the development of product strategic plans he or she liaises with other members of the product team to generate innovative ideas and create buy‑in to strategies.
• Accountable for end‑to‑end delivery of HEOR book of work under their remit, from strategy development to content pull‑through.
• Accountable to ensuring strong partnership with all relevant HEOR COE functions to ensure a comprehensive HEOR voice is represented in cross‑functional meetings.
• Executive presence and ability to engage with senior leaders in a cross‑functional setting.

• Advanced degree in health economics or related discipline.
• Minimum of seven years working experience with Master’s, five years with PhD (can include fellowship experience). Professional training in a health field (MD, Pharm
  
  D, etc.) is a plus.
• Preferred:
  PhD in Economics, Econometrics, and (pharmaco) epidemiology or any other related field with 3 years of relevant experience. Clinical research experience strongly recommended; within pharmaceutical industry preferred. Experience leading complex products and/or clinical development in support of pipeline development and global launch.
• Proven leadership skills in a cross‑functional global team environment. Ability to interact externally and internally to support global business strategy.
• The Director must perform at times in previously uncharted territory with few, if any, established guidelines or procedures. At other times, exceedingly complex governmental rules and regulations must be followed. For problems surrounded by complex rules and regulations, the Director must be able to direct compliance knowledgeably and expeditiously.
• Must be able to develop creative and effective solutions to inter‑ and intra‑project priority conflicts, resource constraints and other problems which may impact project or group goals and deliverables across multiple programs.
• High goal‑orientation with the ability to see solutions rather than problems as projects encounter the inevitable ups and downs associated with new drug development or on‑market product support.
• Extensive knowledge of the global regulatory, HTA and PRA landscape, as well…